Undoubtedly the Hinge Health IPO filing was the big news this week, and as we have spent the past few years covering the company’s activities in women’s health, I thought it’d be fitting to talk about this journey and also what this recent development could mean for the digital health category as a whole. It has been a while since we last saw a digital health IPO so many (including me!) are watching this development with great interest.
If you haven't come across Hinge Health, they are essensially a digital health company that offers virtual physical therapy services. The company’s overall goal is making high-quality musculoskeletal (MSK) care accessible to everyone.
Digital Health's Public Market Test
For those of us analyzing digital health trends on the regular, Hinge represents a somewhat critical test case. Unlike many pandemic-era digital health companies that rushed to market with unproven business models, Hinge enters the public arena with substantive revenue ($390.4M in 2024) and improving financial metrics. The company has successfully navigated the challenging self-insured employer landscape and built a sustainable business in a quite competitive space.
What makes this IPO particularly noteworthy is its timing. Despite recent market volatility, Hinge is moving forward, which suggests confidence in the business regardless of broader economic headwinds.
Hinge Health's Strategic Expansion into Women's Health
What's most fascinating from my perspective is of course Hinge's methodical push into women's health over the past three years. It wasn't an overnight pivot but rather an evolution:
First came their pelvic health program launch in 2022, establishing their initial offering. Then a partnership with specialized pelvic health technology provider Perifit in 2023 to enhance their capabilities. By 2024, they'd entered a relationship with Midi Health to address menopause care comprehensively. Most recently, they've validated their approach with clinical research showing a 53% reduction in chronic pelvic pain.
This progression reveals something crucial about the future of digital health. The llines between traditionally separate health categories are blurring. MSK issues don't exist in isolation from hormonal health, particularly for women. The realization that many perimenopausal and menopausal women experience musculoskeletal pain creates natural adjacencies between different domains.
Hinge's expansion strategy offers a glimpse into how women's health might evolve from a relatively underfunded space into an integrated component of mainstream healthcare platforms.
The traditional approach to women's health technology has been fragmented – separate solutions for fertility, menopause, pelvic health, and pregnancy. But this siloed approach creates challenges for both patients and payers, who increasingly resist managing dozens of so-called point solutions.
By integrating women's specific musculoskeletal needs into their broader platform, Hinge demonstrates a model where women's health isn't treated as a separate category but recognized as an essential element of care. Arguably this integration approach may deliver more value than standalone women's health platforms that struggle to achieve scale.
Post-IPO Scenarios
Assuming a successful offering, Hinge will likely accelerate its category expansion strategy with fresh capital. For women's health innovation, this could create several potential scenarios:
- Hinge could become an acquirer of specialized women's health companies that complement their movement-based approach
- Other digital health platforms might copy Hinge's expansion playbook, leading to increased partnership opportunities for women's health startups
- The valuation metrics established by Hinge's public offering will create benchmarks that influence private market valuations
Looking Forward
Right now the digital health sector seems to stand at a crossroad. After years of boom-and-bust cycles, companies like Hinge offer a potential template for sustainable growth. Start with a focused clinical area, build credibility through outcomes data, expand methodically into adjacent conditions, and maintain financial discipline throughout.
The next six months will reveal much about the state of digital health investing and whether the sector has truly matured beyond its volatile adolescence into a stable industry capable of producing enduring public companies.
